Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Molidustat - Bayer HealthCare Pharmaceuticals

Next Previous
X
Search
Drug Profile

Molidustat - Bayer HealthCare Pharmaceuticals

Alternative Names: BAY-1053048; BAY-853934; HIF-PH inhibitor - Bayer; Hypoxia-inducible factor-prolyl hydroxylase inhibitor - Bayer; Molidustat sodium - Bayer HealthCare Pharmaceuticals; Musredo

Latest Information Update: 25 Sep 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bayer Schering Pharma
  • Developer Bayer HealthCare Pharmaceuticals
  • Class Antianaemics; Morpholines; Pyrazoles; Pyrazolones; Pyrimidines; Small molecules; Triazoles
  • Mechanism of Action Hypoxia-inducible factor-proline dioxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Registered Anaemia

Most Recent Events

  • 25 Sep 2024 Chemical structure information added.
  • 09 Sep 2024 No development reported - Phase-II for Anaemia in Australia, USA, Hungary, Bulgaria, Italy, South Korea, Romania, United Kingdom, Poland, Germany, France, Turkey, Spain, Israel (PO)
  • 22 Jan 2021 Preregistration for Anaemia in Japan (PO) before April 2020

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top